Investing Profile

Michal Silverberg

Managing Director at Novartis Venture Fund -NVF

Your Intro Paths to Michal Silverberg

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Michal is a member of

Hotmail Network

4926 CONNECTIONS

Hotmail Network

4926 CONNECTIONS

Columbia University in the City of New York Network

262 CONNECTIONS

Columbia University Network

152 CONNECTIONS

University of Haifa Network

13 CONNECTIONS

Find Michal Silverberg on

Current Investing Position

Investment Range

$5.0M - $10.0M

Sweet Spot

$7.5M

Investments On Record

Current Fund Size

$750M

Michal Silverberg is on these Sector & Stage Rankings

Michal Silverberg's Investments On Record (3)

Company	StageDateRound Size	Total Raised
Fore Biotherapeutics	Series DJul 2026$67M Series DMay 2025$40M Series DAug 2023$75M	$250M
Co-investors: Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Simeon J. George (SR One), Ran Nussbaum (Pontifax Venture Capital), Chandra Leo (HBM Partners AG), Matthew Foy (SROne)
Sidewinder Therapeutics	Series BApr 2026$140M	$140M
Co-investors: John Hamer (DCVC (Data Collective)), Daniel Estes (Frazier Healthcare Partners)
Twentyeight-Seven Therapeutics	Series AMay 2019$15M Series ASep 2018$65M	$80M
Co-investors: Kazumi Shiosaki (MPM Capital), Henrijette Richter (Sofinnova Partners)

Michal Silverberg's Experience

VP Business Development and Operation MultiGene Vascular Systems (MGVS) LtdPresent

Manager Business Development HotmailPresent

Senior Director Business Development and New Product Commercialization Novo NordiskPresent

Managing Director HotmailPresent

Senior Partner Takeda Ventures, Inc.Present

Michal Silverberg's Education

University of Haifa BA Economics & Business

Columbia University MA Biotechnology

Columbia University in the City of New York MA Biotechnology

Investors who invest with Michal Silverberg

Scouts & Angels Affiliated With Michal Silverberg